^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

KMT2C mutation + BCOR mutation + KDM5C mutation

i
Other names: KMT2C, MLL3, Lysine Methyltransferase 2C, Histone-Lysine N-Methyltransferase 2C, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 3, Lysine (K)-Specific Methyltransferase 2C, Histone-Lysine N-Methyltransferase, H3 Lysine-4 Specific, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3, Histone-Lysine N-Methyltransferase MLL3, Lysine N-Methyltransferase 2C, ALR-Like Protein, KLEFS2, BCOR, BCL6 Corepressor, BCL6 Interacting Corepressor, BCL-6 Corepressor, BCL-6 Coreceptor, BCL-6 Interacting Corepressor, BCL6 Co-Repressor, FLJ20285, MCOPS2, ANOP2, KDM5C, Lysine Demethylase 5C, Jumonji, AT Rich Interactive Domain 1C (RBP2-Like), Jumonji/ARID Domain-Containing Protein 1C, Lysine (K)-Specific Demethylase 5C, Lysine-Specific Demethylase 5C, Histone Demethylase JARID1C, DXS1272E, JARID1C, XE169,Jumonji, AT Rich Interactive Domain 1C, JmjC Domain-Containing Protein SMCX ,Mental Retardation, X-Linked 13, Smcy Homolog, X-Linked (Mouse), Smcx Homolog, X Chromosome, Smcy Homolog, X-Linked, Protein Xe169, Protein SmcX, MRXSCJ, MRXSJ, MRX13, MRXJ
Entrez ID:
Related biomarkers:
News
Trials